Senate File 470 - Introduced


                                 SENATE FILE 

                                 SENATE FILE 
                                 SENATE FILE                                  SENATE FILE                                  BY  COMMITTEE ON HUMAN
                                     RESOURCES

                                 (SUCCESSOR TO SF 282)

                                 (COMPANION TO HF 520
                                     BY COMMITTEE ON PUBLIC
                                     SAFETY)

 A BILL FOR

  1 An Act relating to the medical use of cannabidiol including the
  2    scheduling of a cannabidiol investigational product approved
  3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.                                       RESOURCES

                                 (SUCCESSOR TO SF 282)

                                 (COMPANION TO HF 520
                                     BY COMMITTEE ON PUBLIC
                                     SAFETY)

 A BILL FOR

  1 An Act relating to the medical use of cannabidiol including the
  2    scheduling of a cannabidiol investigational product approved
  3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.  
                                 (SUCCESSOR TO SF 282)

                                 (COMPANION TO HF 520
                                     BY COMMITTEE ON PUBLIC
                                     SAFETY)

 A BILL FOR

  1 An Act relating to the medical use of cannabidiol including the
  2    scheduling of a cannabidiol investigational product approved
  3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.                                   (SUCCESSOR TO SF 282)

                                 (COMPANION TO HF 520
                                     BY COMMITTEE ON PUBLIC
                                     SAFETY)

 A BILL FOR

  1 An Act relating to the medical use of cannabidiol including the
  2    scheduling of a cannabidiol investigational product approved
  3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.  
                                 (COMPANION TO HF 520
                                     BY COMMITTEE ON PUBLIC
                                     SAFETY)

 A BILL FOR

  1 An Act relating to the medical use of cannabidiol including the
  2    scheduling of a cannabidiol investigational product approved
  3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.                                   (COMPANION TO HF 520
                                     BY COMMITTEE ON PUBLIC
                                     SAFETY)

 A BILL FOR

  1 An Act relating to the medical use of cannabidiol including the
  2    scheduling of a cannabidiol investigational product approved
  3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.                                       BY COMMITTEE ON PUBLIC
                                     SAFETY)

 A BILL FOR

  1 An Act relating to the medical use of cannabidiol including the
  2    scheduling of a cannabidiol investigational product approved
  3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.                                       SAFETY)

 A BILL FOR

  1 An Act relating to the medical use of cannabidiol including the
  2    scheduling of a cannabidiol investigational product approved
  3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.  
 A BILL FOR

  1 An Act relating to the medical use of cannabidiol including the
  2    scheduling of a cannabidiol investigational product approved
  3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.   A BILL FOR

  1 An Act relating to the medical use of cannabidiol including the
  2    scheduling of a cannabidiol investigational product approved
  3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.  
  1 An Act relating to the medical use of cannabidiol including the
  2    scheduling of a cannabidiol investigational product approved
  3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.    1 An Act relating to the medical use of cannabidiol including the
  2    scheduling of a cannabidiol investigational product approved
  3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.    2    scheduling of a cannabidiol investigational product approved
  3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.    3    as a prescription drug medication under federal law and
  4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.    4    including effective date provisions.
  5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.    5 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.      TLSB 2301SV (3) 87
    rh/rj

PAG LIN



  1  1    Section 1.      rh/rj

PAG LIN



  1  1    Section 1.  

  1  1    Section 1.  
  1  1    Section 1.    1  1    Section 1.    1  2 investigational product ==== rules.
  1  3    1.  If a cannabidiol investigational product approved as
  1  4 a prescription drug medication by the United States food and
  1  5 drug administration is eliminated from or revised in the
  1  6 federal schedule of controlled substances by the federal drug
  1  7 enforcement agency and notice of the elimination or revision
  1  8 is given to the board, the board shall similarly eliminate
  1  9 or revise the prescription drug medication in the schedule
  1 10 of controlled substances under this chapter.  Such action by
  1 11 the board shall be immediately effective upon the date of
  1 12 publication of the final regulation containing the elimination
  1 13 or revision in the federal register.
  1 14    2.  The board shall adopt rules pursuant to chapter 17A
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1  3    1.  If a cannabidiol investigational product approved as
  1  4 a prescription drug medication by the United States food and
  1  5 drug administration is eliminated from or revised in the
  1  6 federal schedule of controlled substances by the federal drug
  1  7 enforcement agency and notice of the elimination or revision
  1  8 is given to the board, the board shall similarly eliminate
  1  9 or revise the prescription drug medication in the schedule
  1 10 of controlled substances under this chapter.  Such action by
  1 11 the board shall be immediately effective upon the date of
  1 12 publication of the final regulation containing the elimination
  1 13 or revision in the federal register.
  1 14    2.  The board shall adopt rules pursuant to chapter 17A
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1  4 a prescription drug medication by the United States food and
  1  5 drug administration is eliminated from or revised in the
  1  6 federal schedule of controlled substances by the federal drug
  1  7 enforcement agency and notice of the elimination or revision
  1  8 is given to the board, the board shall similarly eliminate
  1  9 or revise the prescription drug medication in the schedule
  1 10 of controlled substances under this chapter.  Such action by
  1 11 the board shall be immediately effective upon the date of
  1 12 publication of the final regulation containing the elimination
  1 13 or revision in the federal register.
  1 14    2.  The board shall adopt rules pursuant to chapter 17A
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1  5 drug administration is eliminated from or revised in the
  1  6 federal schedule of controlled substances by the federal drug
  1  7 enforcement agency and notice of the elimination or revision
  1  8 is given to the board, the board shall similarly eliminate
  1  9 or revise the prescription drug medication in the schedule
  1 10 of controlled substances under this chapter.  Such action by
  1 11 the board shall be immediately effective upon the date of
  1 12 publication of the final regulation containing the elimination
  1 13 or revision in the federal register.
  1 14    2.  The board shall adopt rules pursuant to chapter 17A
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1  6 federal schedule of controlled substances by the federal drug
  1  7 enforcement agency and notice of the elimination or revision
  1  8 is given to the board, the board shall similarly eliminate
  1  9 or revise the prescription drug medication in the schedule
  1 10 of controlled substances under this chapter.  Such action by
  1 11 the board shall be immediately effective upon the date of
  1 12 publication of the final regulation containing the elimination
  1 13 or revision in the federal register.
  1 14    2.  The board shall adopt rules pursuant to chapter 17A
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1  7 enforcement agency and notice of the elimination or revision
  1  8 is given to the board, the board shall similarly eliminate
  1  9 or revise the prescription drug medication in the schedule
  1 10 of controlled substances under this chapter.  Such action by
  1 11 the board shall be immediately effective upon the date of
  1 12 publication of the final regulation containing the elimination
  1 13 or revision in the federal register.
  1 14    2.  The board shall adopt rules pursuant to chapter 17A
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1  8 is given to the board, the board shall similarly eliminate
  1  9 or revise the prescription drug medication in the schedule
  1 10 of controlled substances under this chapter.  Such action by
  1 11 the board shall be immediately effective upon the date of
  1 12 publication of the final regulation containing the elimination
  1 13 or revision in the federal register.
  1 14    2.  The board shall adopt rules pursuant to chapter 17A
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1  9 or revise the prescription drug medication in the schedule
  1 10 of controlled substances under this chapter.  Such action by
  1 11 the board shall be immediately effective upon the date of
  1 12 publication of the final regulation containing the elimination
  1 13 or revision in the federal register.
  1 14    2.  The board shall adopt rules pursuant to chapter 17A
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 10 of controlled substances under this chapter.  Such action by
  1 11 the board shall be immediately effective upon the date of
  1 12 publication of the final regulation containing the elimination
  1 13 or revision in the federal register.
  1 14    2.  The board shall adopt rules pursuant to chapter 17A
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 11 the board shall be immediately effective upon the date of
  1 12 publication of the final regulation containing the elimination
  1 13 or revision in the federal register.
  1 14    2.  The board shall adopt rules pursuant to chapter 17A
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 12 publication of the final regulation containing the elimination
  1 13 or revision in the federal register.
  1 14    2.  The board shall adopt rules pursuant to chapter 17A
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 13 or revision in the federal register.
  1 14    2.  The board shall adopt rules pursuant to chapter 17A
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 14    2.  The board shall adopt rules pursuant to chapter 17A
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 15 to administer this section.  The board may adopt rules on an
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 16 emergency basis as provided in section 17A.4, subsection 3, and
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 17 section 17A.5, subsection 2, to administer this section, and
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 18 the rules shall be effective immediately upon filing unless
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 19 a later date is specified in the rules.  Any emergency rules
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 20 adopted in accordance with this section shall also be published
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 21 as a notice of intended action as provided in section 17A.4,
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 22 subsection 1.
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 23    Sec. 2.  REPEAL.  Section 124D.8, Code 2017, is repealed.
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 24    Sec. 3.  EFFECTIVE DATE.  The section of this Act repealing
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 25 section 124D.8, Code 2017, takes effect June 30, 2017.
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 26                           EXPLANATION
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 27 The inclusion of this explanation does not constitute agreement with
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 28 the explanation's substance by the members of the general assembly.
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 29    This bill relates to the medical use of cannabidiol,
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 30 including the scheduling of a cannabidiol investigational
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 31 product approved as a prescription drug medication under
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 32 federal law.
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 33    The bill provides if a cannabidiol investigational product
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 34 approved as a prescription drug medication by the United States
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  1 35 food and drug administration is eliminated from or revised in
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2  1 the federal schedule of controlled substances by the federal
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2  2 drug enforcement agency and notice of the elimination or
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2  3 revision is given to the board, the board of pharmacy shall
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2  4 similarly eliminate or revise the prescription drug medication
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2  5 in the schedule of controlled substances under Code chapter
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2  6 124.  Such action by the board shall be immediately effective
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2  7 upon the date of publication of the final regulation containing
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2  8 the elimination or revision in the federal register.
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2  9    The bill provides that the board shall adopt rules pursuant
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2 10 to Code chapter 17A to administer the bill and may adopt
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2 11 emergency rules which shall be effective immediately upon
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2 12 filing unless a later date is specified in the rules.  Any
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2 13 emergency rules adopted shall also be published as a notice of
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2 14 intended action as provided in Code section 17A.4, subsection
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2 15 1.
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2 16    The bill strikes the repeal of Code chapter 124D (medical
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2 17 cannabidiol Act) before the repeal becomes effective July 1,
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
  2 18 2017.
       LSB 2301SV (3) 87
       rh/rj
       LSB 2301SV (3) 87
       rh/rj
       rh/rj
